Home Cart Sign in  
Chemical Structure| 6153-64-6 Chemical Structure| 6153-64-6

Structure of Oxytetracycline dihydrate
CAS No.: 6153-64-6

Chemical Structure| 6153-64-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Oxytetracycline Dihydrate is an antibiotic produced by Streptomyces rimosus with antimicrobial spectrum of both Gram-negative and Gram-positive bacteria.

Synonyms: Oxytetracycline(dihydrate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Oxytetracycline dihydrate

CAS No. :6153-64-6
Formula : C22H28N2O11
M.W : 496.46
SMILES Code : O=C(C1=C(O)[C@@H](N(C)C)[C@@]([C@@H](O)[C@@]2([H])C(C(C3=C(O)C=CC=C3[C@]2(O)C)=O)=C4O)([H])[C@@]4(O)C1=O)N.[H]O[H].[H]O[H]
Synonyms :
Oxytetracycline(dihydrate)
MDL No. :MFCD00151234

Safety of Oxytetracycline dihydrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Isoform Comparison

Biological Activity

Description
Oxytetracycline dihydrate, similar to its hydrochloride counterpart, is a potent antibiotic in the tetracycline class, inhibiting a wide range of Gram-negative and Gram-positive bacteria. It also acts as a protein synthesis inhibitor and possesses anti-HSV-1 activity, showcasing its broad antimicrobial and antiviral effects[1].[2].[3].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01809444 Thyroid Associated Opthalmopat... More >>hies Less << Phase 2 Phase 3 Unknown January 2016 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Yong Zhong, MD    +86-10-69156114    yzhong_eye@yahoo.com.cn    China, Guangdong Zhongshan Ophthalmic Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Dan Liang, MD    0086-20-87331766    liangd2@mail.sysu.edu.cn    JOINT SHANTOU INTERNATIONALL EYE CENTER of Shantou University and the Chinese University of Hong Kong Recruiting Shantou, Guangdong, China, 515041 Contact: Mingzhi Zhang, MD    +86-754-88393501    zmz@jsiec.org    Shenzhen Eye Hospital Recruiting Shenzhen, Guangdong, China, 518040 Contact: Guiqin Liu, MD    +86-755-23959600    liuguiqin9@yahoo.com.cn    China, Henan Henan Eye Institue, Henan, China Recruiting Zhengzhou, Henan, China, 450003 Contact: Liya wang, MD    0086-13937169191    wangliya55@126.com    China, Hunan The second xiangya hospital of central south university Recruiting Changsha, Hunan, China, 410011 Contact: Wei Xiong, MD    0086-138-0846-9035    weixiong420@163.com Less <<
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<
NCT01727973 Graves Ophthalmopathy ... More >> Graves Disease Eye Diseases Thyroid Diseases Endocrine System Diseases Eye Diseases, Hereditary Hyperthyroidism Autoimmune Diseases Immune System Diseases Less << Phase 1 Phase 2 Completed - China, Guangdong ... More >> Zhongshan Ophthalmic Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02203682 Graves Ophthalmopathy ... More >> Graves Disease Eye Diseases Thyroid Diseases Endocrine System Diseases Eye Diseases, Hereditary Hyperthyroidism Autoimmune Diseases Immune System Diseases Less << Phase 2 Unknown July 2015 China, Guangdong ... More >> Zhongshan Ophthalmic Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Dan Liang, MD    0086-20-87331766    liangd2@mail.sysu.edu.cn Less <<
NCT01886560 Eye Burns Phase 2 Phase 3 Unknown September 2014 China, Guangdong ... More >> Zhongshan Ophthalmic Center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Dan Liang, MD    0086-20-87331766    liangd2@mail.sysu.edu.cn Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.01mL

0.40mL

0.20mL

10.07mL

2.01mL

1.01mL

20.14mL

4.03mL

2.01mL

References

 

Historical Records

Categories